| Substance P & Analogs | ||
| Peptide Name | CAT# | Peptide Sequence |
| Antagonist G | 1966-2-1 | Arg-DTrp-NMe-Phe-DTrp-Leu-Met-NH2 |
| Scyliorhinin I, amide, dogfish | 1966-2-2 | Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 |
| Scyliorhinin II, amide, dogfish | 1966-2-3 | Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2 |
| Spantide II | 1966-2-4 | DLys(Nicotinoyl)-Pro-(3-Pyridyl)Ala-Pro-(3,4-dichloro)DPhe-Asn-DTrp-Phe-DTrp-Leu-Nle-NH2 |
| Substance P | 1966-2-5 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (1-4) | 1966-2-6 | Arg-Pro-Lys-Pro |
| Substance P (1-7) | 1966-2-7 | Arg-Pro-Lys-Pro-Gln-Gln-Phe |
| Substance P (1-9) | 1966-2-8 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly |
| Substance P (2-11)/Deca-Substance P | 1966-2-9 | Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (3-11)/Nona-Substance P | 1966-2-10 | Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (4-11)/Octa-Substance P | 1966-2-11 | Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (5-11)/Hepta-Substance P | 1966-2-12 | Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (6-11)/Hexa-Substance P | 1966-2-13 | Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (7-11) | 1966-2-14 | Phe-Phe-Gly-Leu-Met-NH2 |
| Substance P (9-11) | 1966-2-15 | Gly-Leu-Met-NH2 |
| Substance P Methyl ester | 1966-2-16 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe |
| Substance P reversed sequence | 1966-2-17 | Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2 |
| Substance P, Free Acid | 1966-2-18 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met |
| Substance P-Gly-Lys-Arg | 1966-2-19 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg |
| [Arg3] Substance P | 1966-2-20 | Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [Asp5,6,Me-Phe8] Substance P | 1966-2-21 | Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 |
| [DAla4] Substance P (4-11) | 1966-2-22 | DAla-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [DArg1,DPhe5,DTrp7,9,Leu11] Substance P | 1966-2-23 | DArg-Pro-Lys-Pro-DPhe-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2 |
| [DArg1,DPro2,DPhe7,DHis9] Substance P | 1966-2-24 | DArg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DHis-Leu-Met-NH2 |
| [DArg1,DPro2,DTrp7,9,Leu11] Substance P | 1966-2-25 | DArg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2 |
| [DArg1,DTrp7,9,Leu11] Substance P | 1966-2-26 | DArg-Pro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2 |
| [Dehydro-Pro4] Substance P (4-11) | 1966-2-27 | Dehydro-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [DPro2,DPhe7,DTrp9] Substance P | 1966-2-28 | Arg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DTrp-Leu-Met-NH2 |
| [DPro2,DTrp7,9] Substance P | 1966-3-1 | Arg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 |
| [DPro4,DTrp7,9,10] Substance P (4-11) | 1966-3-2 | DPro-Gln-Gln-DTrp-Phe-DTrp-DTrp-Met-NH2 |
| [DPro4,DTrp7,9,Nle11] Substance P (4-11) | 1966-3-3 | DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Nle-NH2 |
| [DPro4,DTrp7,9] Substance P (4-11) | 1966-3-4 | DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 |
| [DTrp2,7,9] Substance P | 1966-3-5 | Arg-DTrp-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2 |
| [Glp5,(Me)Phe8,Sar9] Substance P (5-11) | 1966-3-6 | Glp-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2 |
| [Glp5,Sar9] Substance P (5-11) | 1966-3-7 | Glp-Gln-Phe-Phe-Sar-Leu-Met-NH2 |
| [Glp5] Substance P (5-11) | 1966-3-8 | Glp-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [Glp6,Pro9] Substance P (6-11)/Septide | 1966-3-9 | Glp-Phe-Phe-Pro-Leu-Met-NH2 |
| [Glp6] Substance P (6-11) | 1966-3-10 | Glp-Phe-Phe-Gly-Leu-Met-NH2 |
| [Gly11] Substance P | 1966-3-11 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2 |
| [His11]Substance P | 1966-3-12 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2 |
| [MePhe8,Sar9] Substance P | 1966-3-13 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2 |
| [Nle11] Substance P | 1966-3-14 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2 |
| [Pro9] Substance P | 1966-3-15 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2 |
| [Sar4] Substance P (4-11) | 1966-3-16 | Sar-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [Sar9, Met(O2)11 | 1966-3-17 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O2]-NH2 |
| [Sar9] Substance P | 1966-3-18 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 |
| [Succinyl-Asp6,Me-Phe8] Substance P | 1966-3-19 | Succinyl-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 |
| [Tyr8,Nle11] Substance P | 1966-3-20 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2 |
| [Tyr8] Substance P | 1966-3-21 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 |
Company
Name: PhtdPeptides. Co.,
Ltd.
Contact: William
wang
Email: phtd012@phtdpeptides.com
Email: phtd012@phtdpeptides.com
web: www.phtdpeptides.com
Skype: william39333
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230
The undecapeptide substance P has a number of peripheral actions which include contraction of smooth muscle, reduction of blood pressure and stimulation of secretory tissues. Substance P also occurs in neurones in the central nervous system. Substance P Acetate
回复删除